| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NEWR | Common Stock | Options Exercise | $507,900 | +30,000 | $16.93* | 30,000 | 07 Mar 2022 | Direct | ||
| transaction | NEWR | Common Stock | Sale | $1,066,513 | -17,725 | -59% | $60.17 | 12,275 | 07 Mar 2022 | Direct | F1, F2 |
| transaction | NEWR | Common Stock | Sale | $629,970 | -10,375 | -85% | $60.72 | 1,900 | 07 Mar 2022 | Direct | F1, F3 |
| transaction | NEWR | Common Stock | Sale | $117,173 | -1,900 | -100% | $61.67 | 0 | 07 Mar 2022 | Direct | F1, F4 |
| holding | NEWR | Common Stock | 5,467,151 | 07 Mar 2022 | By Trust | F5 | |||||
| holding | NEWR | Common Stock | 274,000 | 07 Mar 2022 | By Trust | F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NEWR | Stock Option (Right to Buy) | Options Exercise | $0 | -30,000 | -9.2% | $0.000000 | 295,000 | 07 Mar 2022 | Common Stock | 30,000 | $16.93 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | Shares sold pursuant to a 10b5-1 plan. |
| F2 | The shares were sold at prices ranging from $59.52 to $60.515. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F3 | The shares were sold at prices ranging from $60.52 to $61.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F4 | The shares were sold at prices ranging from $61.53 to $61.94. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F5 | Shares are held directly by Lewis Cirne and Kirsten L. Vliet, as Trustees of the Cirne Family Revocable Trust UAD March 20, 2012. |
| F6 | The shares are held directly by J.P. Morgan Trust Company of Delaware, as Trustee of the Cirne Family 2012 Irrevocable Trust. |
| F7 | Fully vested and exercisable. |